Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bartlomiej J. Witczak"'
Autor:
Bartlomiej J. Witczak, Søren E. Pischke, Anna V. Reisæter, Karsten Midtvedt, Judith K. Ludviksen, Kristian Heldal, Trond Jenssen, Anders Hartmann, Anders Åsberg, Tom E. Mollnes
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe major reason for graft loss is chronic tissue damage, as interstitial fibrosis and tubular atrophy (IF/TA), where complement activation may serve as a mediator. The association of complement activation in a stable phase early after kidn
Externí odkaz:
https://doaj.org/article/381cdef388294bcfa91422c31b67ebd6
Autor:
Ingrid Benedicte Moss Kolseth, Trond Jenssen, Svein Olav Kolset, Amanda Sudworth, Trine M. Reine, Krystina Parker, Bartlomiej J Witczak
Publikováno v:
Journal of diabetes and its complications. 31(1)
Aims To investigate and describe the relationship between diabetic nephropathy and systemic inflammation in patients with type 1 diabetes mellitus (T1DM). Methods Patients with T1DM, with or without reduced renal function due to diabetic nephropathy,
Publikováno v:
American Journal of Transplantation. 6:2403-2408
We evaluated the incidence of significant coronary artery stenoses (CAS), angina pectoris (AP), revascularization and associated risk factors in 155 consecutive diabetic nephropathy transplant candidates. Kidney and kidney-pancreas transplant candida
Autor:
Karsten Midtvedt, Bartlomiej J Witczak, Hallvard Holdaas, Trond Jenssen, Anna Varberg Reisæter, Torbjørn Leivestad, Pål-Dag Line, Anders Hartmann, Jan Bitter
Publikováno v:
Transplantation. 88(5)
Preemptive kidney transplantation (PKT) is increasingly acknowledged. We wanted to investigate the results of an active PKT policy in an unselected end-stage renal disease population with high prevalence of PKT.From 1989 to 2007, 3400 first kidney tr
Publikováno v:
Transplantation. 84(3)
Background. There is a high incidence of silent coronary artery disease (CAD) in patients with diabetes. We wanted to investigate risk factors for mortality, and especially CAD, in a well-defined cohort of diabetic nephropathy transplant candidates a